SEASTAR MEDICAL HOLDING CORP
ICU · NASDAQ
Updated at 2026-10-14 09:27:48
- Today's High
- $3.92
- Today’s Low
- $3.50
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.55
- Previous Close
- $3.85
- Volume
- 116.29K
- Market Cap
- $16.96M
- P/E Ratio
- --
- EPS
- $-3.92
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3513 BRIGHTON BOULEVARD, DENVER, CO, UNITED STATES, 80216
- Country
- US
- Listing Date
- 2021-01-26
- Fiscal Year End
- December
- Shares Outstanding
- 4M
- CIK
- 0001831868
- Website
- seastarmedical.com
SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via its proprietary technologies designed to improve renal function and minimize invasive procedures. Operating in a dynamic market with significant unmet medical demands, SeaStar's strong commitment to clinical innovation is underpinned by an extensive R&D pipeline and strategic collaborations. As the company strives to deliver transformative advancements in renal health, it presents substantial investment opportunities for institutional investors focused on the biotechnology landscape.
Financial Metrics
Revenue
2026-06-30
$615K
2026-03-31
$495K
2025-12-31
$420K
2025-09-30
$183K
Operating Expenses
2026-06-30
$4.35M
2026-03-31
$4.05M
2025-12-31
$3.42M
2025-09-30
$3.74M
Net Income
2026-06-30
-$3.73M
2026-03-31
-$3.52M
2025-12-31
-$2.9M
2025-09-30
-$3.47M
Net Profit Margin
2026-06-30
-606.5%
2026-03-31
-711.31%
2025-12-31
-691.42%
2025-09-30
-1.89K%
Earnings Per Share
2026-06-30
$-0.91
2026-03-31
$-0.90
2025-12-31
$-0.80
2025-09-30
$-1.30
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.71M
2026-03-31
-$3.59M
2025-12-31
-$2.89M
2025-09-30
$107K
Effective Tax Rate
2026-06-30
--
2026-03-31
-0.08%
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $615K | $495K | $420K | $183K |
| Operating Expenses | $4.35M | $4.05M | $3.42M | $3.74M |
| Net Income | -$3.73M | -$3.52M | -$2.9M | -$3.47M |
| Net Profit Margin | -606.5% | -711.31% | -691.42% | -1.89K% |
| Earnings Per Share | $-0.91 | $-0.90 | $-0.80 | $-1.30 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.71M | -$3.59M | -$2.89M | $107K |
| Effective Tax Rate | -- | -0.08% | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.